Methanesulfonamide → N-[2-(4'-tert-butyl-5-fluoro-biphenyl-3-yl)-3,3-dimethyl-1,2,3,4-tetrahydro-quinoline-6-carbonyl]-methanesulfonamide
반응식
[C:1]([C:5]1[CH:10]=[CH:9][C:8]([C:11]2[CH:16]=[C:15]([F:17])[CH:14]=[C:13]([CH:18]3[C:27]([CH3:29])([CH3:28])[CH2:26][C:25]4[C:20](=[CH:21][CH:22]=[C:23]([C:30](O)=[O:31])[CH:24]=4)[NH:19]3)[CH:12]=2)=[CH:7][CH:6]=1)([CH3:4])([CH3:3])[CH3:2].[CH3:33][S:34]([NH2:37])(=[O:36])=[O:35]>CN(C)C1C=CN=CC=1.ClCCl>[C:1]([C:5]1[CH:10]=[CH:9][C:8]([C:11]2[CH:16]=[C:15]([F:17])[CH:14]=[C:13]([CH:18]3[C:27]([CH3:29])([CH3:28])[CH2:26][C:25]4[C:20](=[CH:21][CH:22]=[C:23]([C:30]([NH:37][S:34]([CH3:33])(=[O:36])=[O:35])=[O:31])[CH:24]=4)[NH:19]3)[CH:12]=2)=[CH:7][CH:6]=1)([CH3:4])([CH3:2])[CH3:3]참가 물질
반응물 2
생성물 1
시약·촉매·용매 2
실험 절차
A mixture of 2-(4′-tert-butyl-5-fluoro-biphenyl-3-yl)-3,3-dimethyl-1,2,3,4-tetrahydro-quinoline-6-carboxylic acid (30 mg, 0.07 mmol), 1-3-dimethylaminopropyl-3-ethylcarbodiimide hydrochloride (20 mg, 0.10 mmol), 4-dimethylaminopyridine (12.2 mg, 0.10 mmol), methane sulfonamide (20 mg, 0.21 mmol) in dichloromethane (10 mL) was refluxed for 12 hours. Removal of the solvent afforded an oil residue. Purification by Waters automated flash system (column: Xterra 30 mm×100 mm, sample manager 2767, pump 2525, detector: ZQ mass and UV 2487, solvent system: acetonitrile and 0.1% formic acid in water) afforded N-[2-(4′-tert-butyl-5-fluoro-biphenyl-3-yl)-3,3-dimethyl-1,2,3,4-tetrahydro-quinoline-6-carbonyl]-methanesulfonamide (11 mg, 30%) as a light yellow solid: LC/MS m/e calcd for C29H33FN2O3S (M+H)+: 509.66, observed: 509.2.
후처리
- temperaturewas refluxed for 12 hours
- customRemoval of the solvent
- customafforded an oil residue
- customPurification by Waters automated flash system (column: Xterra 30 mm×100 mm, sample manager 2767, pump 2525, detector: ZQ mass and UV 2487, solvent system: acetonitrile and 0.1% formic acid in water)
출처 및 근거
- ORD 기록
- ord-3b666c49216a44a3a446c5c3810b9629
- 출처 데이터셋
- uspto-grants-2013_11
- 특허 번호
- US08586747B2
반응 노트
불러오는 중…